ONCOLYS BIOPHARMA INC. · オンコリスバイオファーマ株式会社
Last · Tokyo¥4605.00+535.00 (+13.14%)stale · yahoo · 197h ago
Market cap¥135.6B29.4M sh
P/E · TTM-87.0fwd -61.4 · eps -52.91 · loss
Beta1.12vs S&P 500
Div yield—annual · TTM
52w range
¥601.00¥4875.00
Volume1.3Msession
| Revenue | ¥503.1M |
|---|---|
| Operating income | ¥-767.6M |
| Free cash flow | ¥-1.0B |
| Operating margin | -152.6% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-03-25
- Operating Cf Burn
- Cash Runway Low
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~1.8 years
- Rd Intensity High — R&D/Revenue 5150.9%